Related Experiment Video
Updated: May 6, 2026

Glomerular Outgrowth as an Ex Vivo Assay to Analyze Pathways Involved in Parietal Epithelial Cell Activation
Published on: August 19, 2020
Overdiagnosis: under-recognized clinical and pathological features of "focal ischemic glomerulosclerosis clustering"
Mingfeng Zhao1, Rui Zhang2, Feilai Xie3
1Department of Pathology, Dongfang Hospital, Fuzhou 350025, China; Department of Pathology, Binzhou Medical University, Binzhou 256603, China.
Abstract:
"Focal ischemic glomerulosclerosis clustering (FIGSC)" is a term used by us temporarily to describe a rare kind of focal renal scar with a high percentage of global sclerosis in the renal biopsy tissue. We retrospectively studied the clinical and pathological data from 15 cases of FIGSC followed up in order to avoid overdiagnosis and to investigate its diagnostic basis. We found that in 7 cases with FIGSC, the percentage of global sclerosis was higher than 50% with mild or moderate tubulointerstitial lesions, and most cases showed sclerotic regions distributed both beneath the renal capsule and in the deep cortex. Fourteen cases of afferent arterioles sclerosis were observed. Fourteen did not evolve to end-stage renal disease (ESRD) during the follow-up period. The values of the percentage of severe tubulointerstitial lesion, SCr, BUN, and the cumulative incidence of ESRD were significantly lower compared to the diffuse proliferative sclerosis glomerulonephritis group (P<0.05). The results suggest that the essence of FIGSC may be a kind of focal renal scar related to sclerosis, stenosis or obstruction of several adjacent afferent arterioles, not caused by original glomerulonephritis. Comprehensive understanding should be very important to avoid overdiagnosis and overtreatment.
Insights
Focal ischemic glomerulosclerosis clustering (FIGSC) presents as a distinct renal scar, often linked to afferent arteriole issues rather than primary glomerulonephritis. This condition shows a better prognosis than diffuse proliferative sclerosis glomerulonephritis, suggesting it
Area of Science:
- Nephrology
- Pathology
- Renal Medicine
Background:
- Focal ischemic glomerulosclerosis clustering (FIGSC) is a rare renal finding characterized by focal scars with significant global sclerosis.
- Distinguishing FIGSC from other glomerular diseases is crucial to prevent misdiagnosis and inappropriate treatment.
Purpose of the Study:
- To investigate the clinical and pathological basis of FIGSC.
- To differentiate FIGSC from diffuse proliferative sclerosis glomerulonephritis and assess its prognostic implications.
Main Methods:
- Retrospective analysis of clinical and pathological data from 15 patients with FIGSC.
- Comparison of FIGSC cases with a diffuse proliferative sclerosis glomerulonephritis group.
Main Results:
- FIGSC cases exhibited high global sclerosis (>50%) with mild/moderate tubulointerstitial lesions and characteristic sclerotic distribution.
- Afferent arteriole sclerosis was noted in 14 cases; 14 patients did not progress to end-stage renal disease (ESRD).
- FIGSC group showed significantly lower rates of severe tubulointerstitial lesions, serum creatinine, BUN, and ESRD incidence compared to the glomerulonephritis group (P<0.05).
Conclusions:
- FIGSC may represent a focal renal scar secondary to afferent arteriole abnormalities (sclerosis, stenosis, obstruction) rather than primary glomerulonephritis.
- Understanding FIGSC is vital for accurate diagnosis, avoiding overdiagnosis, and optimizing patient management.
More Related Videos
09:16Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
Published on: June 18, 2020
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Related Concept Videos
Nephrotic Syndrome I : Introduction
Diabetic Nephropathy
Hypertension III: Clinical Manifestations and Diagnostic Studies
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Diabetic Retinopathy